share_log

Cynata Therapeutics Ltd: EU Approval for Phase 2 CYP-001 Trial in GvHD

Mar 20 05:55
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.